Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

Corn rootworm-active RNA DvSnf7: Repeat dose oral toxicology assessment in support of human and mammalian safety.

Petrick JS, Frierdich GE, Carleton SM, Kessenich CR, Silvanovich A, Zhang Y, Koch MS.

Regul Toxicol Pharmacol. 2016 Jul 16. pii: S0273-2300(16)30192-1. doi: 10.1016/j.yrtph.2016.07.009. [Epub ahead of print]

2.

Associations of NSAID and paracetamol use with risk of primary liver cancer in the Clinical Practice Research Datalink.

Yang B, Petrick JL, Chen J, Hagberg KW, Sahasrabuddhe VV, Graubard BI, Jick S, McGlynn KA.

Cancer Epidemiol. 2016 Aug;43:105-11. doi: 10.1016/j.canep.2016.06.009. Epub 2016 Jul 13.

PMID:
27420633
3.

International trends in liver cancer incidence, overall and by histologic subtype, 1978-2007.

Petrick JL, Braunlin M, Laversanne M, Valery PC, Bray F, McGlynn KA.

Int J Cancer. 2016 Oct 1;139(7):1534-45. doi: 10.1002/ijc.30211. Epub 2016 Jun 28.

PMID:
27244487
4.

Obesity, diabetes, serum glucose, and risk of primary liver cancer by birth cohort, race/ethnicity, and sex: Multiphasic health checkup study.

Petrick JL, Freedman ND, Demuth J, Yang B, Van Den Eeden SK, Engel LS, McGlynn KA.

Cancer Epidemiol. 2016 Jun;42:140-6. doi: 10.1016/j.canep.2016.04.009. Epub 2016 May 2.

PMID:
27148890
5.

Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030.

Petrick JL, Kelly SP, Altekruse SF, McGlynn KA, Rosenberg PS.

J Clin Oncol. 2016 May 20;34(15):1787-94. doi: 10.1200/JCO.2015.64.7412. Epub 2016 Apr 4.

PMID:
27044939
6.

Temporal trends of esophageal disorders by age in the Cerner Health Facts database.

Petrick JL, Nguyen T, Cook MB.

Ann Epidemiol. 2016 Feb;26(2):151-4.e1-4. doi: 10.1016/j.annepidem.2015.11.004. Epub 2015 Dec 11.

PMID:
26762962
7.

Clinical Interventions to Promote Breastfeeding by Latinas: A Meta-analysis.

Wouk K, Lara-Cinisomo S, Stuebe AM, Poole C, Petrick JL, McKenney KM.

Pediatrics. 2016 Jan;137(1). doi: 10.1542/peds.2015-2423. Epub 2015 Dec 14. Review.

PMID:
26668300
8.

NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project.

Petrick JL, Sahasrabuddhe VV, Chan AT, Alavanja MC, Beane-Freeman LE, Buring JE, Chen J, Chong DQ, Freedman ND, Fuchs CS, Gaziano JM, Giovannucci E, Graubard BI, Hollenbeck AR, Hou L, Jacobs EJ, King LY, Koshiol J, Lee IM, Linet MS, Palmer JR, Purdue MP, Rosenberg L, Schairer C, Sesso HD, Sigurdson AJ, Wactawski-Wende J, Zeleniuch-Jacquotte A, Campbell PT, McGlynn KA.

Cancer Prev Res (Phila). 2015 Dec;8(12):1156-62. doi: 10.1158/1940-6207.CAPR-15-0126. Epub 2015 Sep 21.

PMID:
26391917
9.

RNAi technologies in agricultural biotechnology: The Toxicology Forum 40th Annual Summer Meeting.

Sherman JH, Munyikwa T, Chan SY, Petrick JS, Witwer KW, Choudhuri S.

Regul Toxicol Pharmacol. 2015 Nov;73(2):671-80. doi: 10.1016/j.yrtph.2015.09.001. Epub 2015 Sep 9.

10.

Dietary flavonoid intake and Barrett's esophagus in western Washington State.

Petrick JL, Steck SE, Bradshaw PT, Chow WH, Engel LS, He K, Risch HA, Vaughan TL, Gammon MD.

Ann Epidemiol. 2015 Oct;25(10):730-5.e2. doi: 10.1016/j.annepidem.2015.05.010. Epub 2015 Jun 5.

PMID:
26169148
11.

Coffee Consumption and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma by Sex: The Liver Cancer Pooling Project.

Petrick JL, Freedman ND, Graubard BI, Sahasrabuddhe VV, Lai GY, Alavanja MC, Beane-Freeman LE, Boggs DA, Buring JE, Chan AT, Chong DQ, Fuchs CS, Gapstur SM, Gaziano JM, Giovannucci EL, Hollenbeck AR, King LY, Koshiol J, Lee IM, Linet MS, Palmer JR, Poynter JN, Purdue MP, Robien K, Schairer C, Sesso HD, Sigurdson AJ, Zeleniuch-Jacquotte A, Wactawski-Wende J, Campbell PT, McGlynn KA.

Cancer Epidemiol Biomarkers Prev. 2015 Sep;24(9):1398-406. doi: 10.1158/1055-9965.EPI-15-0137. Epub 2015 Jun 30.

PMID:
26126626
12.

Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability.

McGlynn KA, Petrick JL, London WT.

Clin Liver Dis. 2015 May;19(2):223-38. doi: 10.1016/j.cld.2015.01.001. Epub 2015 Feb 26. Review.

13.

Geographic variation of intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and hepatocellular carcinoma in the United States.

Altekruse SF, Petrick JL, Rolin AI, Cuccinelli JE, Zou Z, Tatalovich Z, McGlynn KA.

PLoS One. 2015 Apr 2;10(3):e0120574. doi: 10.1371/journal.pone.0120574. eCollection 2015.

14.
15.

Reproductive factors, exogenous hormone use and risk of hepatocellular carcinoma among US women: results from the Liver Cancer Pooling Project.

McGlynn KA, Sahasrabuddhe VV, Campbell PT, Graubard BI, Chen J, Schwartz LM, Petrick JL, Alavanja MC, Andreotti G, Boggs DA, Buring JE, Chan AT, Freedman ND, Gapstur SM, Hollenbeck AR, Hou L, King LY, Koshiol J, Linet M, Palmer JR, Poynter JN, Purdue M, Robien K, Schairer C, Sesso HD, Sigurdson A, Wactawski-Wende J, Zeleniuch-Jacquotte A.

Br J Cancer. 2015 Mar 31;112(7):1266-72. doi: 10.1038/bjc.2015.58.

16.

Authors' Response to Letter to the Editor by Heinemann et al. "Response to 'A 28-day oral toxicity evaluation of small interfering RNAs and a long double-stranded RNA targeting vacuolar ATPase in mice.'" 2015.

Petrick JS, Moore WM, Heydens WF, Koch MS, Sherman JH, Lemke SL.

Regul Toxicol Pharmacol. 2015 Apr;71(3):597-8. doi: 10.1016/j.yrtph.2015.02.004. Epub 2015 Feb 13. No abstract available.

PMID:
25683774
17.

Dietary intake of flavonoids and oesophageal and gastric cancer: incidence and survival in the United States of America (USA).

Petrick JL, Steck SE, Bradshaw PT, Trivers KF, Abrahamson PE, Engel LS, He K, Chow WH, Mayne ST, Risch HA, Vaughan TL, Gammon MD.

Br J Cancer. 2015 Mar 31;112(7):1291-300. doi: 10.1038/bjc.2015.25.

18.

A 28-day oral toxicity evaluation of small interfering RNAs and a long double-stranded RNA targeting vacuolar ATPase in mice.

Petrick JS, Moore WM, Heydens WF, Koch MS, Sherman JH, Lemke SL.

Regul Toxicol Pharmacol. 2015 Feb;71(1):8-23. doi: 10.1016/j.yrtph.2014.10.016. Epub 2014 Nov 15.

19.

Trajectory of overall health from self-report and factors contributing to health declines among cancer survivors.

Petrick JL, Foraker RE, Kucharska-Newton AM, Reeve BB, Platz EA, Stearns SC, Han X, Windham BG, Irwin DE.

Cancer Causes Control. 2014 Sep;25(9):1179-86. doi: 10.1007/s10552-014-0421-3. Epub 2014 Jul 2.

20.

Functional status declines among cancer survivors: trajectory and contributing factors.

Petrick JL, Reeve BB, Kucharska-Newton AM, Foraker RE, Platz EA, Stearns SC, Han X, Windham BG, Irwin DE.

J Geriatr Oncol. 2014 Oct 1;5(4):359-67. doi: 10.1016/j.jgo.2014.06.002. Epub 2014 Jun 26.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk